about
Varicella-zoster virusShingles Immunity and Health Functioning in the Elderly: Tai Chi Chih as a Behavioral TreatmentUniversal varicella vaccination: efficacy trends and effect on herpes zosterSimian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans.Varicella-zoster virus immune evasion.Chickenpox at Ninety Four: A Case for Extending the Use of Varicella Vaccine in the UK.Postherpetic neuralgia in the cancer patient.Upregulation of CXCL10 in human dorsal root ganglia during experimental and natural varicella-zoster virus infection.Human sensory neurons derived from induced pluripotent stem cells support varicella-zoster virus infection.Seroepidemiologic survey of varicella-zoster virus in korean adults using glycoprotein enzyme immuno assay and fluorescent antibody to membrane antigen testRisk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort studyChanges in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen loadVaricella-zoster virus glycoproteins B and E are major targets of CD4+ and CD8+ T cells reconstituting during zoster after allogeneic transplantation.Effector and Central Memory Poly-Functional CD4(+) and CD8(+) T Cells are Boosted upon ZOSTAVAX(®) VaccinationThe ORF47 and ORF66 putative protein kinases of varicella-zoster virus determine tropism for human T cells and skin in the SCID-hu mouse.The effect of ultraviolet radiation on human viral infections.Genome-wide analysis of T cell responses during acute and latent simian varicella virus infections in rhesus macaquesVaricella-zoster virus glycoprotein I is essential for spread in dorsal root ganglia and facilitates axonal localization of structural virion components in neuronal cultures.Shingles vaccine.Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus.Case-control study of the effect of mechanical trauma on the risk of herpes zoster.Varicella-zoster virus productively infects mature dendritic cells and alters their immune function.Immunogenicity of a two-dose regime of varicella vaccine in children with cancers.Pathophysiology and clinical manifestations of varicella zoster virus infections.Varicella in pediatric patients.Varicella zoster virus quantitation in blood from symptomatic and asymptomatic individuals.Induction of cellular immunity to varicella-zoster virus glycoproteins tested with pernasal coadministration of Escherichia coli enterotoxin in mice.Herpes zoster following cryosurgery.Simian varicella virus antibody response in experimental infection of African green monkeys.The case against universal varicella vaccination.
P2860
Q24683811-E0A07389-E16C-44D4-9005-409499D9DCD6Q24808895-6034B4CA-9D4E-46CE-9CAF-D7F3DD2C5F7EQ28269376-F138A08F-F697-4F0E-BB57-6F159F3AC171Q30884283-6C5455B0-1BE5-4B47-BE77-830DD330CDCFQ33683365-4FB57029-B038-4C12-9884-1F400BF12AC4Q33943156-A8E37A0F-62A8-4C72-886D-9D7622F7E73FQ34040576-7DB129D7-19D6-4819-A5B9-FD8F3816C9BCQ34457932-AB777894-B288-46E3-BA7E-1C613C5CC7B1Q34534963-1D58853F-5DC6-434F-83AB-09B49D4BBCC9Q35059642-88232F8F-8A06-4BA5-90BA-9166B3D522DAQ35556161-8EA833B5-18A9-45CB-81BC-A4372E61CCF0Q35784804-EFD9E037-084B-45F6-B887-4C274FD45CA1Q36006384-E616BCC0-0895-41C9-8572-C8FE8D217B9EQ36237622-1A30F2E3-0F8F-48E7-9C47-43DB139DA0E6Q36327713-C7C7F941-1CD3-4A77-9CFE-77E5C91E5494Q36611727-9265AA2E-26DF-4B00-81E6-6AA279A5BEB5Q37252780-4C07F6F4-79A0-43B9-94E9-0D3A5D28D209Q37336873-FE3D007E-2B87-4F0F-9FCA-22DE091D6EFEQ37683770-34574A85-3DBB-4CC1-968F-58B6AF8EDEEBQ39508564-955EAF96-AD76-47D3-9B4A-2D44722FD3EEQ39521701-15580352-54E0-4D8C-97DE-6ECE0ACFDC1DQ39742020-7494CC32-5992-4E92-A63C-262D55DDE85EQ40536886-2216AE6A-D866-4449-B223-9A3416BADD1DQ40666511-C0EB0229-52EE-4338-967D-787488EEBA00Q40715633-BAEEDB81-DAB3-434E-ACC1-8A8DB8192E74Q42259029-4422167F-5A6F-4F54-BF5A-E22484B7B076Q44276964-E371C58B-5BF2-47D0-BCB3-4D36D8EFC4BFQ45237915-90928364-7E00-4387-BE1C-83BCB4C5999EQ45769080-429A210D-A503-489B-8896-A82CDCE0FD79Q46988238-680C76B4-9F49-4665-8269-D9562278EE11
P2860
description
1992 nî lūn-bûn
@nan
1992 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Cell-mediated immunity to varicella-zoster virus.
@ast
Cell-mediated immunity to varicella-zoster virus.
@en
type
label
Cell-mediated immunity to varicella-zoster virus.
@ast
Cell-mediated immunity to varicella-zoster virus.
@en
prefLabel
Cell-mediated immunity to varicella-zoster virus.
@ast
Cell-mediated immunity to varicella-zoster virus.
@en
P1476
Cell-mediated immunity to varicella-zoster virus.
@en
P2093
P304
P356
10.1093/INFDIS/166.SUPPLEMENT_1.S35
P407
P478
166 Suppl 1
P577
1992-08-01T00:00:00Z